These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10211520)

  • 1. CD44 expression in benign and malignant colorectal polyps.
    Neumayer R; Rosen HR; Reiner A; Sebesta C; Schmid A; Tüchler H; Schiessel R
    Dis Colon Rectum; 1999 Jan; 42(1):50-5. PubMed ID: 10211520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminin 5 gamma 2 chain expression: a marker of early invasiveness in colorectal adenomas.
    Lenander C; Roblick UJ; Habermann JK; Ost A; Tryggvason K; Auer G
    Mol Pathol; 2003 Dec; 56(6):342-6. PubMed ID: 14645697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Genomic mRNA Profiling of Colorectal Adenomas: Identification and
    Hartmans E; Orian-Rousseau V; Matzke-Ogi A; Karrenbeld A; de Groot DJ; de Jong S; van Dam GM; Fehrmann RS; Nagengast WB
    Theranostics; 2017; 7(2):482-492. PubMed ID: 28255344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of CD44 splicing variants in advanced colorectal carcinomas.
    Weg-Remers S; Anders M; von Lampe B; Riecken EO; Schüder G; Feifel G; Zeitz M; Stallmach A
    Eur J Cancer; 1998 Sep; 34(10):1607-11. PubMed ID: 9893637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 splice variants as prognostic markers in colorectal cancer.
    Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
    Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
    Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
    Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
    Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
    J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
    Tempfer C; Lösch A; Heinzl H; Häusler G; Hanzal E; Kölbl H; Breitenecker G; Kainz C
    Eur J Cancer; 1996 Oct; 32A(11):2023-5. PubMed ID: 8943691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum.
    Jackson PA; Green MA; Pouli A; Hubbard R; Marks CG; Cook MG
    J Clin Pathol; 1995 Dec; 48(12):1098-101. PubMed ID: 8567994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sessile serrated adenomas of the large bowel. Clinicopathologic and immunohistochemical study including comparison with common hyperplastic polyps and adenomas.
    Chlumská A; Boudová L; Zámecník M
    Cesk Patol; 2006 Jul; 42(3):133-8. PubMed ID: 16955561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma.
    Asao T; Nakamura J; Shitara Y; Tsutsumi S; Mochiki E; Shimura T; Takenoshita S; Kuwano H
    Dis Colon Rectum; 2000 Sep; 43(9):1250-4; discussion 1254-5. PubMed ID: 11005492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
    Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
    J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44V6 expression in human colorectal carcinoma.
    Coppola D; Hyacinthe M; Fu L; Cantor AB; Karl R; Marcet J; Cooper DL; Nicosia SV; Cooper HS
    Hum Pathol; 1998 Jun; 29(6):627-35. PubMed ID: 9635685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucins in the colorectal neoplastic spectrum with reference to conventional and serrated adenomas.
    Perçinel S; Savaş B; Ensari A; Kuzu I; Kuzu MA; Bektaş M; Cetinkaya H; Kurşun N
    Turk J Gastroenterol; 2007 Dec; 18(4):230-8. PubMed ID: 18080919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein CD44 expression in colorectal neoplasms. An immuno-histochemical study including correlation with cathepsin D, extracellular matrix components, p53, Rb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim E; Goussia A; Agnantis NJ
    Virchows Arch; 1999 Jan; 434(1):45-50. PubMed ID: 10071234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
    García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
    Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma.
    Wang L; Liu Q; Lin D; Lai M
    Int J Clin Exp Pathol; 2015; 8(11):14283-93. PubMed ID: 26823744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of the human CD44 gene in early colorectal malignancy with special reference to variant exon 9 (9v).
    Kawahara K; Yoshino T; Kawasaki N; Miyake K; Akagi T
    J Clin Pathol; 1996 Jun; 49(6):478-81. PubMed ID: 8763262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act".
    Sheridan TB; Fenton H; Lewin MR; Burkart AL; Iacobuzio-Donahue CA; Frankel WL; Montgomery E
    Am J Clin Pathol; 2006 Oct; 126(4):564-71. PubMed ID: 16938659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.